Find your next paid study

Children's Oncology GroupNCT05711667

~$10 – $7,500

Phase 1

A Phase I Trial of CD19-targeted Chimeric Antigen Receptor (CAR) T Cells That Constitutively Secrete Interleukin 18 (19-28z/IL-18) in Patients With Relapsed or Refractory (R/R) Acute Lymphoblastic Leukemia (ALL)

Participants will have a sample of their white blood cells, called T cells, collected using a procedure called leukapheresis. The collected T cells will be sen…

Philadelphia-Negative ALLPhiladelphia-Positive ALLRelapsed ALL, Adult+3 more

Memorial Sloan Kettering Cancer CenterNCT06287528

Protocol for Immunology Specimen Collection From Cancer Patients, Patients With Hematologic Diagnoses, and Healthy Normal Controls

This research trial collects and stores blood, tissue, and bone marrow specimens from patients with cancer or blood disorders, and healthy volunteers to study …

Healthy SubjectHematologic and Lymphocytic DisorderHematopoietic and Lymphoid Cell Neoplasm+2 more

University of Southern CaliforniaNCT03207854

~$10 – $750

Hematopoietic and Lymphoid System NeoplasmHereditary Malignant NeoplasmMalignant Solid Neoplasm

Family HOPE Study (Hereditary Lynch Syndrome Opportunities for Participation &Amp; Engagement)

This clinical trial tests whether provider-mediated communication of genetic testing results to at-risk relatives of cancer patients can help improve genetic c…

City of Hope Medical CenterNCT05772130

Phase 2

Placebo-Controlled and Randomized Phase 2 Trial of CMV-MVA Triplex Vaccination in HLA-Matched Related Stem Cell Donors to Enhance CMV-Specific Immunity and Prevent CMV Viremia in Recipients After Hematopoietic Stem Cell Transplant

This phase II clinical trial tests how well the cytomegalovirus-modified vaccinica Ankara (CMV-MVA) Triplex vaccine given to human leukocyte antigens (HLA) mat…

Acute Lymphoblastic LeukemiaAcute Myeloid LeukemiaChronic Lymphocytic Leukemia+7 more

City of Hope Medical CenterNCT06059391

Hematopoietic and Lymphoid Cell NeoplasmMalignant Solid Neoplasm

TEAM Me (Totally Excited About Moving, Mobility, and Exercise) Clinical Research Protocol

This clinical trial studies how well an exercise program (Totally Excited About Moving, Mobility, and Exercise \[TEAM Me\]) affects the exercise and dietary ha…

M.D. Anderson Cancer CenterNCT04678427

Phase 1

An Open Label, Phase 1/2 Study Evaluating Immunomodulatory AVM0703 in Patients With Lymphoid Malignancies (OPAL Study)

This is an open-label, Phase 1/2 study designed to characterize the safety, tolerability, Pharmacokinetics(PK), and preliminary antitumor activity of AVM0703 a…

Lymphoid Malignancies

AVM Biotechnology IncNCT04329728

~$10 – $8,750

Clonal Hematopoiesis and Therapy-Emergent Myeloid Neoplasms in Patients With Cancers (CHANCES)

This study is being done to investigate clonal hematopoiesis and therapy-emergent myeloid neoplasms in patients with ovarian or other solid cancers. Researcher…

Recurrent Fallopian Tube CarcinomaRecurrent Ovarian CarcinomaRecurrent Primary Peritoneal Carcinoma+7 more

University of WashingtonNCT06295965

~$10 – $750

Adjustment DisorderAnxiety DisorderDepression+3 more

Pilot Study to Assess Safety, Tolerability and Efficacy of Virtual Reality in Cancer Patients

This clinical trial tests the safety, tolerability, and effectiveness of a virtual reality intervention to improve psychological symptom burden for cancer pati…

Mayo ClinicNCT07221409

Hematopoietic and Lymphoid System NeoplasmMalignant Solid Neoplasm

Determining the Impact of a Curriculum for a Cancer Survivorship Group for Adolescents and Young Adults (AYA)

This clinical trial studies the effectiveness of a group curriculum in improving survivorship outcomes in adolescent and young adult (AYA) cancer survivors. Ma…

Hematopoietic and Lymphoid Cell Neoplasm

Mayo ClinicNCT05584449

Outcomes After Chimeric Antigen Receptor Therapy (CAR-T) and Radiation Therapy (RT) for Hematologic Malignancies

This study collects information on outcomes after chimeric antigen receptor therapy and radiation therapy for hematologic malignancies. Collecting information …

M.D. Anderson Cancer CenterNCT04888338

~$10 – $750

Phase 1

Phase 1/1b Safety and Tolerability Trial of CD19 Directed CAR T Cells in Adult Patients With B-Cell Acute Lymphoblastic Leukemia (B-ALL) With Minimal Residual Disease (MRD) Positivity at First Complete Remission

This open-label, single arm Phase 1/1b trial aims to determine the safety and tolerability of anti-CD19 chimeric antigen receptor-expressing (CAR) T cells (UCD…

Acute Lymphoid LeukemiaAcute Lymphoblastic Leukemia